Cloud Data Engineer
About the job
- At least 7 years of experience in data engineering, data platform, or analytics engineering roles with a strong cloud focus.
- Deep expertise in AWS data services, including S3, Glue, EMR, Redshift, Athena, Lambda, Kinesis, Step Functions, and Lake Formation.
- Strong programming skills in Python and SQL, with experience using PySpark or similar big data frameworks.
- Proficiency building ETL/ELT pipelines at scale and experience with data orchestration tools such as Airflow, Step Functions, or Prefect.
- Solid understanding of data modeling, data warehousing, and dimensional design, including star and snowflake schemas.
- Experience with Infrastructure as Code using Terraform and CI/CD pipelines for data infrastructure.
- Strong understanding of data governance, security, and compliance best practices.
- Strong problem-solving skills and attention to data quality and reliability.
- Strong communication and collaboration skills, with the ability to work with technical and non-technical stakeholders.
- Design, build, and maintain scalable data pipelines and ETL/ELT workflows on AWS using services such as Glue, EMR, Lambda, Step Functions, Kinesis, and S3.
- Implement data ingestion from databases, APIs, streaming platforms, and third-party providers, ensuring reliability, performance, and error handling.
- Develop and optimize data transformation logic using SQL, Python, PySpark, or similar frameworks, ensuring data quality, consistency, and lineage.
- Design and implement AWS data storage solutions using S3 data lakes, Redshift data warehouses, DynamoDB, RDS, and Aurora, optimizing for cost, performance, and access patterns.
- Build and maintain Terraform Infrastructure as Code for data infrastructure, following team standards for modules, state management, and Terraform Enterprise workflows.
- Implement CI/CD pipelines for data workflows using GitHub, Bamboo, GitLab, or similar tools, including automated testing, deployment, and monitoring.
- Establish data governance and security controls, including encryption at rest and in transit, IAM policies, data classification, audit logging, and regulatory compliance.
- Collaborate with Analytics Engineers, Data Analysts, and ML Engineers to understand data requirements and deliver datasets optimized for downstream consumption.
- Monitor and troubleshoot data pipeline performance, failures, and data quality issues, and implement proactive alerting and remediation.
- Partner with Cloud Architecture, Cloud Security, and Database teams to align data infrastructure with enterprise standards and best practices.
- Document data pipelines, data models, and operational procedures, and contribute to the team knowledge base.
- Drive automation and reduce toil using GenAI and agentic workflows to improve engineering productivity.
- Implement AI agent-driven automation for data engineering tasks such as data quality checks, anomaly detection, and pipeline optimization, with human-in-the-loop validation, comprehensive logging and auditability, data-corruption guardrails, rollback mechanisms, and secure credential handling.
- Identify data engineering toil and ship automation that measurably reduces manual work and improves pipeline reliability.
- Monitor data pipeline health and service-level agreements and respond promptly to failures and data quality incidents.
- Participate in an on-call rotation as needed for critical data workflows.
- Conduct post-incident reviews for data pipeline failures and track corrective actions to completion.
- Maintain runbooks and operational documentation for data infrastructure.
- Continuously improve pipeline performance, cost efficiency, and data quality.
- Familiarity with streaming data platforms such as Kafka, Kinesis, or MSK.
- AWS Certified Data Analytics or Big Data Specialty certification.
- Experience with Snowflake or Databricks for data processing and analytics.
- Familiarity with dbt for transformation workflows.
- Background in software engineering or site reliability engineering.
- Experience with data catalog and metadata management tools such as AWS Glue Catalog, Collibra, or Alation.
- Knowledge of DataOps practices and data quality frameworks.
About the company
Jefferies is a global, full‑service investment banking and capital markets firm that helps investors, companies, and governments with advisory services, sales and trading, research, and wealth and asset management. It uses a worldwide network of more than 40 offices to deliver market insights and financial solutions to clients. Its products include advisory services for mergers and restructurings, capital markets execution, securities research, and portfolio management for individuals and institutions. The goal is to guide clients through financial markets, raise capital, and grow wealth across geographies and asset classes.
Company Size
5,001-10,000
Company Stage
IPO
Headquarters
New York City, New York
Founded
1854
Get referred to Jefferies
See people who can refer or advise you
Simplify's Take
What believers are saying
- The SMBC joint venture launches in January 2027, opening Japan equities and ECM.
- Q3 2026 advisory revenue rose 25% and equity underwriting jumped 69%.
- Jefferies raised buyback authorization to $250 million and kept a $0.40 dividend.
What critics are saying
- Asset-management revenue fell 55% sequentially in Q3 2026 after First Brands and Radiant World losses.
- Western Alliance sued Jefferies in March 2026 over a $126.4 million unpaid loan.
- Another First Brands-style scandal would cripple Jefferies' reputation and trading-client trust.
What makes Jefferies unique
- SMBC now owns about 20%, giving Jefferies a powerful Japanese distribution alliance.
- Jefferies posted record Q3 2026 investment-banking revenue of $1.33 billion.
- Its equities franchise generated a quarterly record $626 million in Q3 2026.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Life Insurance
Wellness Program
Company News
Jefferies has identified three undervalued biotechnology stocks with strong commercial prospects despite challenging macroeconomic conditions. Delphia Therapeutics' oral psychedelic DT120 has produced three positive Phase III datasets for major depressive disorder and generalized anxiety disorder. Jefferies estimates $1.5 billion or more in peak sales per indication, implying a $9 billion valuation against the current $5 billion market cap. Axsome Therapeutics' Auvelity is approved for major depressive disorder and Alzheimer's agitation. Management's peak sales guidance of $8 billion for Auvelity suggests significant upside. BridgeBio Pharma is positioned to launch four blockbuster oral medications. Attruby could reach $3-4 billion in US peak sales, whilst three additional billion-dollar products will launch in 2027. The firm noted rising interest rates are pressuring small and mid-cap biotech companies, potentially shifting investor focus toward late-stage and commercial-stage names.
Jefferies has named Molbio Diagnostics its top pick in India's medical supplies sector, initiating coverage with a Buy rating and a price target of INR1,600. The brokerage projects revenue compound annual growth rate of 22% and profit after tax CAGR of 47% through FY26-29E. Founded in 2000, Molbio has developed the Truenat platform, an ultra-portable molecular diagnostics system that represents 86% of FY26 sales. The platform, built after 13 years of research, supports testing for 30 diseases and is patent-protected in over 100 countries. Jefferies expects margin expansion of approximately 830 basis points, driven by rising test-kit capacity utilisation and the scaling of Molbio's Optrascan platform to 11% of sales by FY29E.
Jefferies: Asset Management issues remain A drag following Q3 2026 earnings. 4.39K Followers Summary. * Jefferies Financial Group posted strong Investment Banking and Capital Markets results in Q3 2026, offsetting significant weakness in Asset Management. * JEF's Asset Management unit suffered a 55% sequential and 52% YoY revenue decline, driven by repeated credit events and reputational setbacks. * Despite group revenues of $2.2B and EPS of $1.08 beating expectations, persistent asset management issues justify the stock's discounted 0.9x book value. * I maintain a 'Hold' rating on JEF, as ongoing credit concerns and weak investor sentiment limit the risk-return appeal for long-term investors. As I've covered some months ago, Jefferies Financial Group (JEF) has reported a positive operating performance in recent quarters, but some issues related to private credit have resulted in negative investor sentiment toward
Jefferies stung by soured bets at asset-management unit. 29 Sep 2026, 09:07 pm (Sept 29): Jefferies Financial Group Inc's asset-management unit revenue slumped more than 50% in the fiscal third quarter, sending shares down as the bank grapples with fallout from tumultuous investments. Net revenue in that business totalled US$85.6 million (RM349 million) in the three months through August, down from almost US$177 million in the same period a year earlier, according to a statement late Monday. That business has been dealing with soured bets on First Brands Group and Radiant World that the firm was exposed to through Leucadia Asset Management's Point Bonita fund. Shares of Jefferies dropped 1.1% in early New York trading, extending this year's decline to more than 25%. "We remain confident in the long-term outlook for the business as we continue to reposition the platform by reducing capital allocated to certain existing funds consistent with the strategy we outlined last fall when we announced our intent to acquire and fund a 50% interest in Hildene," chief executive officer Richard Handler and president Brian Friedman said in the statement. In 2025, Jefferies agreed to buy a 50% stake in Hildene Holding Co, a credit-focused asset manager that the bank had had a strategic relationship with for years. The firm's asset-management woes overshadowed a record quarter for Jefferies' stock traders and investment bankers. Equity-trading revenue surged 29% from a year earlier to US$626 million, boosted by cash and electronic trading as well as the prime services business that works with hedge funds. Revenue at the investment-banking business rose 17% to US$1.3 billion. That was driven by a 25% gain in the advisory unit and a 69% increase in the equity-underwriting business. In recent months, Radiant World has come under scrutiny amid allegations of fraud. Jefferies' exposure to Radiant World was less than US$300 million, Bloomberg previously reported. Fixed income. Jefferies' fixed-income trading business also had a tougher quarter, hit by a sluggish market that drove a 26% decrease in net revenue. Still, equity trading was "robust," even if questions are arising about how sustainable it can be, according to Vital Knowledge's Adam Crisafulli. The quarter was OK, he said. "Not amazing, not horrible." Earnings per share totalled US$1.08 in the period, surpassing the US$1 average estimate of analysts in a Bloomberg survey. Jefferies is the first of the major US banks to post third-quarter results, setting a benchmark for Wall Street firms that report in October. The results offer a look into how investment-banking businesses have held up despite market volatility. "We are very optimistic about the balance of 2026 and our momentum heading into 2027, supported by the breadth and strength of our current backlog and new business activity," Handler and Friedman said in the statement. The bank's quarter is also a positive sign for Wall Street's other equity-trading desks, many of which had already started hinting at how good the quarter was shaping up. Bank of America Corp. CEO Brian Moynihan said equity trading climbed in the quarter through the middle of September, while Goldman Sachs Group Inc's David Solomon said equity trading has remained "very strong." Fixed-income trading, however, has been softer in some parts of Wall Street. Bank of America has cautioned that revenue in the business was down and bouncing around. Uploaded by Magessan Varatharaja
Jefferies surpasses profit estimates on strong dealmaking. Jefferies Financial (JEF.N) has exceeded third-quarter profit estimates, propelled by strong performance in its advisory and stock underwriting businesses. The New York-based investment bank, which advises on deals, underwrites stock sales, and operates trading desks and an asset management business, reported profit attributable to shareholders of $260.6 million, or $1.08 per share, for the three months ended August 31. This comfortably surpassed the average analyst estimate of $1 per share, according to LSEG data. The company's investment banking revenue saw a significant 17% jump, reaching $1.33 billion, underpinned by record advisory business performance and robust equity underwriting. Revenue from its capital markets segment, encompassing Jefferies' trading desks, also climbed 11% to $802 million, driven by record equities trading. These results offer an early indication of broader investment banking trends on Wall Street, arriving ahead of major US banks' earnings reports in coming weeks, and align with a global dealmaking environment that has exceeded $4 trillion this year. Despite the overall strong showing, Jefferies' asset management business faced headwinds. Fees and investment return revenue in this division shrank considerably to $34 million, down from $84 million a year earlier. This decline reflects weaker performance across several fund strategies, notably Point Bonita, which held exposure to the bankrupt auto-parts supplier First Brands. Looking forward, CEO Richard Handler and President Brian Friedman expressed optimism for 2026 and momentum into 2027, citing strong backlog and new business activity, while also affirming confidence in the long-term outlook for the asset management platform. However, the firm's shares were down 1.5% in extended trading, contributing to an approximate 24% decline this year.